CN101967120A - Preparation method of 2-p-chlorobenzyl pyridine - Google Patents
Preparation method of 2-p-chlorobenzyl pyridine Download PDFInfo
- Publication number
- CN101967120A CN101967120A CN2010100456228A CN201010045622A CN101967120A CN 101967120 A CN101967120 A CN 101967120A CN 2010100456228 A CN2010100456228 A CN 2010100456228A CN 201010045622 A CN201010045622 A CN 201010045622A CN 101967120 A CN101967120 A CN 101967120A
- Authority
- CN
- China
- Prior art keywords
- pyridyl
- chlorobenzylpyridine
- chlorophenyl
- reaction
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XSVWMIMFDMJQRL-UHFFFAOYSA-N 2-[(4-chlorophenyl)methyl]pyridine Chemical compound C1=CC(Cl)=CC=C1CC1=CC=CC=N1 XSVWMIMFDMJQRL-UHFFFAOYSA-N 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 27
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims abstract description 25
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 21
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims abstract description 19
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims abstract description 9
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims abstract description 7
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 150000002576 ketones Chemical class 0.000 claims abstract description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract 3
- IHIZJRICNGUMFO-UHFFFAOYSA-N formyl chloride;hydrochloride Chemical compound Cl.ClC=O IHIZJRICNGUMFO-UHFFFAOYSA-N 0.000 claims abstract 3
- 230000035484 reaction time Effects 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 5
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 abstract description 26
- 229960003291 chlorphenamine Drugs 0.000 abstract description 23
- 238000000034 method Methods 0.000 abstract description 11
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
- KHXSJSBQIWAIEG-UHFFFAOYSA-N (4-chlorophenyl)-pyridin-2-ylmethanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1=CC=CC=N1 KHXSJSBQIWAIEG-UHFFFAOYSA-N 0.000 description 22
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 18
- 239000007787 solid Substances 0.000 description 15
- 238000010992 reflux Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- SIOXPEMLGUPBBT-UHFFFAOYSA-N Picolinic acid Natural products OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 6
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- VXKWYPOMXBVZSJ-UHFFFAOYSA-N tetramethyltin Chemical compound C[Sn](C)(C)C VXKWYPOMXBVZSJ-UHFFFAOYSA-N 0.000 description 6
- VIPHVHVAGBKHGR-UHFFFAOYSA-N hydron;pyridine-2-carbonyl chloride;chloride Chemical compound Cl.ClC(=O)C1=CC=CC=N1 VIPHVHVAGBKHGR-UHFFFAOYSA-N 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- PSAYJRPASWETSH-UHFFFAOYSA-N pyridine-2-carbonyl chloride Chemical compound ClC(=O)C1=CC=CC=N1 PSAYJRPASWETSH-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- ULDFXQCHLBJYFL-UHFFFAOYSA-N 2-benzyl-4-chloropyridine Chemical compound ClC1=CC=NC(CC=2C=CC=CC=2)=C1 ULDFXQCHLBJYFL-UHFFFAOYSA-N 0.000 description 1
- WQMAANNAZKNUDL-UHFFFAOYSA-N 2-dimethylaminoethyl chloride Chemical compound CN(C)CCCl WQMAANNAZKNUDL-UHFFFAOYSA-N 0.000 description 1
- UTLDQPSPINRRLM-UHFFFAOYSA-N 4-(pyridin-2-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CC1=CC=CC=N1 UTLDQPSPINRRLM-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- -1 N,N-dimethylaminoethyl chloride Alkanes Chemical class 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical group C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 229940045803 cuprous chloride Drugs 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- CKJNUZNMWOVDFN-UHFFFAOYSA-N methanone Chemical compound O=[CH-] CKJNUZNMWOVDFN-UHFFFAOYSA-N 0.000 description 1
- HFAFXVOPGDBAOK-UHFFFAOYSA-M pyridine-2-carboxylate;hydrochloride Chemical compound [Cl-].OC(=O)C1=CC=CC=N1 HFAFXVOPGDBAOK-UHFFFAOYSA-M 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Landscapes
- Pyridine Compounds (AREA)
Abstract
一种2-对氯苄基吡啶的制备方法,先向2-吡啶甲酰氯盐酸盐中加入氯苯和三氯化铝反应,得1-(4-氯苯基)-1-(2-吡啶基)甲酮;再向制得的1-(4-氯苯基)-1-(2-吡啶基)甲酮加入一缩二乙二醇、水合肼和氢氧化钾反应,得2-对氯苄基吡啶。用本发明方法生产的2-对氯苄基吡啶,作为制备扑尔敏的中间体,产品纯度高、工艺简便、用其制备的扑尔敏产品符合中国药典,而且成本低、易于工业化,有显著的经济效益和社会效益。A kind of preparation method of 2-p-chlorobenzylpyridine, first adds chlorobenzene and aluminum trichloride reaction in 2-pyridine formyl chloride hydrochloride, obtains 1-(4-chlorophenyl)-1-(2- pyridyl) ketone; then add diethylene glycol, hydrazine hydrate and potassium hydroxide to the prepared 1-(4-chlorophenyl)-1-(2-pyridyl) ketone to react to obtain 2- 4-chlorobenzylpyridine. With the 2-p-chlorobenzylpyridine produced by the inventive method, as the intermediate for preparing chlorpheniramine, the product purity is high, the process is simple and convenient, the chlorpheniramine product prepared with it meets the Chinese Pharmacopoeia, and the cost is low, easy to industrialization, and has Significant economic and social benefits.
Description
技术领域technical field
本发明属制备药物扑尔敏的中间体2-对氯苄基吡啶的制备方法。 The invention belongs to the preparation method of the intermediate 2-p-chlorobenzylpyridine of the medicine chlorpheniramine. the
背景技术Background technique
扑尔敏Chlorpheniramine,别名:氯苯那敏。为抗组胺药,主要用于各种过敏性疾病,如虫咬、荨麻疹、血管舒张性鼻炎、哮喘、接触性皮炎等。还可以与其它中、西医药结合,治疗感冒等。扑尔敏药物凭借其强的抗过敏活性且较小的副作用在抗过敏药物中一直占有重要地位。 Chlorpheniramine, alias: Chlorpheniramine. It is an antihistamine, mainly used for various allergic diseases, such as insect bites, urticaria, vasodilatory rhinitis, asthma, contact dermatitis, etc. It can also be combined with other Chinese and Western medicines to treat colds and so on. Chlorpheniramine has always occupied an important position in antiallergic drugs by virtue of its strong antiallergic activity and relatively small side effects. the
2-对氯苄基吡啶是制备扑尔敏药物的重要中间体,其相关的制备技术也有不少报导,传统的制备方法是用2-甲基吡啶通过氯化后再与苯胺在PH=1时进行缩合反应得2-对氨基苄基吡啶,然后再将其通过重氮化与氯化亚铜反应得2-对氯苄基吡啶。这种传统的制备方法不仅步骤多,且反应条件要求高。 2-p-chlorobenzylpyridine is an important intermediate for preparing chlorpheniramine, and its related preparation technology has many reports. The traditional preparation method is to use 2-picoline after chlorination with aniline at pH=1 Condensation reaction is carried out at the time to obtain 2-p-aminobenzylpyridine, and then it is reacted with cuprous chloride through diazotization to obtain 2-p-chlorobenzylpyridine. This traditional preparation method not only has many steps, but also requires high reaction conditions. the
发明内容Contents of the invention
本发明要解决的技术问题是提供一种步骤少、工艺流程短、反应条件要求低的制备2-对氯苄基吡啶的方法。 The technical problem to be solved by the present invention is to provide a method for preparing 2-p-chlorobenzylpyridine with few steps, short process flow and low requirements on reaction conditions. the
本发明以如下技术方案解决上述技术问题: The present invention solves the above technical problems with the following technical solutions:
制备的工艺步骤为: The process steps of preparation are:
(1).制备1-(4-氯苯基)-1-(2-吡啶基)甲酮 (1). Preparation of 1-(4-chlorophenyl)-1-(2-pyridyl)methanone
向2-吡啶甲酰氯盐酸盐中加入摩尔比为1∶10的氯苯,以三氯化铝为催化剂,2-吡啶甲酰氯盐酸盐与催化剂的摩尔比为1∶2~5,反应温度195~150℃,反应时间3~10小时,得1-(4-氯苯基)-1-(2-吡啶基)甲酮; Adding chlorobenzene with a molar ratio of 1:10 to 2-pyridineformyl chloride hydrochloride, using aluminum trichloride as a catalyst, the molar ratio of 2-pyridineformyl chloride hydrochloride to the catalyst is 1:2~5, and the reaction The temperature is 195-150°C, and the reaction time is 3-10 hours to obtain 1-(4-chlorophenyl)-1-(2-pyridyl)methanone;
(2).制备2-对氯苄基吡啶 (2). Preparation of 2-p-chlorobenzylpyridine
以一缩二乙二醇为溶剂,加入1-(4-氯苯基)-1-(2-吡啶基)甲酮、质量百分比为85%的水合肼和氢氧化钾,加入的摩尔比分别为1∶5∶2,反应温度为190-220℃,反应时间3-10小时。得2-对氯苄基吡啶。 Using diethylene glycol as a solvent, add 1-(4-chlorophenyl)-1-(2-pyridyl)methanone, hydrazine hydrate and potassium hydroxide with a mass percentage of 85%, and the molar ratios added are respectively The ratio is 1:5:2, the reaction temperature is 190-220°C, and the reaction time is 3-10 hours. In 2-p-chlorobenzylpyridine. the
用本发明方法生产的2-对氯苄基吡啶,作为制备扑尔敏的中间体,产品纯度高、工艺简便、用其制备的扑尔敏产品符合中国药典,而且成本低、易于工业化,有显著的经济效益和社会效益。 With the 2-p-chlorobenzylpyridine produced by the inventive method, as the intermediate for preparing chlorpheniramine, the product purity is high, the process is simple and convenient, the chlorpheniramine product prepared with it meets the Chinese Pharmacopoeia, and the cost is low, easy to industrialization, and has Significant economic and social benefits. the
the
具体实施方式Detailed ways
本发明中的2-对氯苄基吡啶,其中间体是1-(4-氯苯基)-1-(2-吡啶基)甲酮。制备1-(4-氯苯基)-1-(2-吡啶基)甲酮的方法是:将初始原料2-吡啶甲酸与氯化亚砜反应生成2-吡啶甲酰氯,反应条件是以氯化亚砜为溶剂,氯化亚砜与2-吡啶甲酸的摩尔比为1∶5,温度为回流,反应时间为3小时。所得的2-吡啶甲酰氯再以氯苯为溶剂,三氯化铝为催化剂,摩尔比为2-吡啶甲酰氯∶氯苯∶三氯化铝=1∶10∶2~3,温度变化范围为95~150℃;反应时间为3~10小时,反应产物为1-(4-氯苯基)-1-(2-吡啶基)甲酮。 The intermediate of 2-p-chlorobenzylpyridine in the present invention is 1-(4-chlorophenyl)-1-(2-pyridyl)methanone. The method for preparing 1-(4-chlorophenyl)-1-(2-pyridyl)methanone is: the initial raw material 2-pyridine carboxylic acid is reacted with thionyl chloride to generate 2-pyridine carboxylic acid chloride, and the reaction condition is based on chlorine Use thionyl chloride as solvent, the molar ratio of thionyl chloride to 2-pyridinecarboxylic acid is 1:5, the temperature is reflux, and the reaction time is 3 hours. The 2-pyridineformyl chloride of gained is solvent again with chlorobenzene, and aluminum trichloride is a catalyst, and the molar ratio is 2-pyridineformyl chloride: chlorobenzene: aluminum trichloride=1: 10: 2~3, and the temperature range is 95~150℃; the reaction time is 3~10 hours, and the reaction product is 1-(4-chlorophenyl)-1-(2-pyridyl)methanone. the
上述反应物的结构式分别为: The structural formulas of the above-mentioned reactants are respectively:
1-(4-氯苯基)-1-(2-吡啶基)甲酮,其结构式为I: 1-(4-chlorophenyl)-1-(2-pyridyl)methanone, its structural formula is I:
2-吡啶甲酰氯的结构式为Ia,氯苯为Ib: The structural formula of 2-pyridinecarbonyl chloride is Ia, and chlorobenzene is Ib:
作为初始原料的2-吡啶甲酸的结构式为Ic: The structural formula of 2-pyridinecarboxylic acid as starting material is Ic:
上述反应得到的产物1-(4-氯苯基)-1-(2-吡啶基)甲酮再以一缩二乙二醇为 溶剂,与85%的水合肼、氢氧化钾混合,在200℃下反应3-10小时,各物质的摩尔比为1∶5∶2。反应产物为2-对氯苄基吡啶。 The product 1-(4-chlorophenyl)-1-(2-pyridyl) ketone that above-mentioned reaction obtains takes diethylene glycol as solvent again, mixes with 85% hydrazine hydrate, potassium hydroxide, at 200 The reaction is carried out at ℃ for 3-10 hours, and the molar ratio of each substance is 1:5:2. The reaction product is 2-p-chlorobenzylpyridine. the
2-对氯苄基吡啶的结构式为II: The structural formula of 2-p-chlorobenzylpyridine is II:
当将2-对氯苄基吡啶作为中间体制备药物扑尔敏时,先要按常规方式制备扑尔敏盐基:即将2-对氯苄基吡啶与N,N-二甲胺基氯乙烷及氨基钠反应,得扑尔敏盐基1-(4-氯苯基)-1-(2-吡啶基)-3-二甲胺基丙烷; When 2-p-chlorobenzylpyridine is used as an intermediate to prepare the drug chlorpheniramine, the chlorpheniramine base will be prepared in a conventional manner: 2-p-chlorobenzylpyridine and N,N-dimethylaminoethyl chloride Alkanes and sodium amide reaction, get chlorpheniramine base 1-(4-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane;
扑尔敏盐基1-(4-氯苯基)-1-(2-吡啶基)-3-二甲胺基丙烷的结构式为III: The structural formula of chlorpheniramine base 1-(4-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane is III:
N,N-二甲胺基氯乙烷的结构式为II a The structural formula of N, N-dimethylaminoethyl chloride is II a
将扑尔敏盐基与顺丁烯二酸成盐即可得扑尔敏成品。 The finished product of chlorpheniramine can be obtained by forming a salt of chlorpheniramine base and maleic acid. the
扑尔敏1-(4-氯苯基)-1-(2-吡啶基)-3-二甲胺基丙烷顺丁烯二酸盐的结构 式为IV: The structural formula of chlorpheniramine 1-(4-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane maleate is IV:
顺丁烯二酸的结构式为IIIa: The structural formula of maleic acid is IIIa:
实施例1 制备2-对氯苄基吡啶 Example 1 Preparation of 2-p-chlorobenzylpyridine
加入2.46g 2-吡啶甲酸于100ml反应瓶中,然后将10ml氯化亚砜于恒压滴液漏斗慢慢加入其中,慢慢升温至回流,反应3小时。停止加热,减压回收剩余的氯化亚砜,得深红色固体为2-吡啶甲酰氯盐酸盐。冰浴条件下加入20ml氯苯,搅拌下慢慢加入5.34g三氯化铝,加毕,继续搅拌,半小时后将反应瓶转入油浴锅中慢慢加热至100℃左右,反应3小时,停止反应。减压回收剩余氯苯,然后在冰浴条件下慢慢加入冰块(20ml水中加有2ml浓盐酸冻制成),反应十分剧烈,应小心加入冰块。再慢慢加入浓NaOH溶液,加至PH为12左右,抽虑得红色固体为1-(4-氯苯基)-1-(2-吡啶基)甲酮和杂质。加入60ml正己烷和3g活性碳加热回流1小时。过滤活性碳得正己烷溶液。最后将正己烷溶液冷却结晶得白色固体为1-(4-氯苯基)-1-(2-吡啶基)甲酮,过滤,水洗,抽干后,于真空干燥箱中50℃干燥得白色粉末固体1-(4-氯苯基)-1-(2-吡啶基)甲酮0.61g。回收正己烷后的残留物经柱层析(硅胶200~300目,洗脱剂:V乙酸乙酯∶V石油醚=1∶3)分离得到产物0.11g,总共得产物1-(4-氯苯基)-1-(2-吡啶基)甲酮0.72g,收率为16.7%,熔点:60-61℃。GC-MS:98%。 Add 2.46g of 2-pyridinecarboxylic acid into a 100ml reaction flask, then slowly add 10ml of thionyl chloride into the constant pressure dropping funnel, slowly raise the temperature to reflux, and react for 3 hours. Heating was stopped, and the remaining thionyl chloride was recovered under reduced pressure to obtain a dark red solid of 2-pyridinecarbonyl chloride hydrochloride. Add 20ml of chlorobenzene under the condition of ice bath, slowly add 5.34g of aluminum trichloride under stirring, continue to stir after adding, after half an hour, transfer the reaction bottle into an oil bath and slowly heat to about 100°C, and react for 3 hours , stop responding. Recover the remaining chlorobenzene under reduced pressure, and then slowly add ice cubes (made by adding 2ml of concentrated hydrochloric acid to 20ml of water) under ice bath conditions. The reaction is very violent, and ice cubes should be added carefully. Then slowly add concentrated NaOH solution until the pH is about 12, and the red solid is 1-(4-chlorophenyl)-1-(2-pyridyl)methanone and impurities by filtration. Add 60ml of n-hexane and 3g of activated carbon and heat to reflux for 1 hour. Filter activated carbon to obtain n-hexane solution. Finally, the n-hexane solution was cooled and crystallized to obtain a white solid 1-(4-chlorophenyl)-1-(2-pyridyl)methanone, which was filtered, washed with water, and dried in a vacuum oven at 50°C to obtain a white solid. 0.61 g of powder solid 1-(4-chlorophenyl)-1-(2-pyridyl)methanone. The residue after recovery of n-hexane was separated by column chromatography (silica gel 200-300 mesh, eluent: V ethyl acetate : V petroleum ether = 1:3) to obtain 0.11 g of the product, and a total of the product 1-(4-chloro Phenyl)-1-(2-pyridyl)methanone 0.72g, yield 16.7%, melting point: 60-61°C. GC-MS: 98%.
取上述方法所制得1-(4-氯苯基)-1-(2-吡啶基)甲酮2.18g,加入一缩二乙二醇6ml,85%水合肼12ml,氢氧化钾1.3g,回流1小时,然后一边升高反应温度一边将反应瓶内的水蒸出。将温度升至190℃,反应3小时。冷却后加入100ml水,用10ml×3甲苯 萃取,回收甲苯后减压蒸馏得无色油状液体2-对氯苄基吡啶1.52g,收率75%;GC-MS:99%。 Take 2.18g of 1-(4-chlorophenyl)-1-(2-pyridyl)methanone obtained by the above method, add 6ml of diethylene glycol, 12ml of 85% hydrazine hydrate, and 1.3g of potassium hydroxide, After reflux for 1 hour, the water in the reaction flask was distilled off while raising the reaction temperature. The temperature was raised to 190° C. and reacted for 3 hours. After cooling, add 100ml of water, extract with 10ml×3 toluene, recover toluene and distill under reduced pressure to obtain 1.52g of colorless oily liquid 2-p-chlorobenzylpyridine, yield 75%; GC-MS: 99%. the
实施例2 制备2-对氯苄基吡啶 Example 2 Preparation of 2-p-chlorobenzylpyridine
加入2.46g 2-吡啶甲酸于100ml反应瓶中,然后将10ml氯化亚砜于恒压滴液漏斗慢慢加入其中,慢慢升温至回流,反应3小时。停止加热,减压回收剩余的氯化亚砜,得深红色固体为2-吡啶甲酰氯盐酸盐。冰浴条件下加入20ml氯苯,搅拌下慢慢加入7.24g三氯化铝,加毕,继续搅拌,半小时后将反应瓶转入油浴锅中慢慢加热至108℃左右,反应6小时,停止反应。减压回收剩余氯苯,然后在冰浴条件下慢慢加入冰块(20ml水中加有2ml浓盐酸冻制成),反应十分剧烈,应小心加入冰块。再慢慢加入浓NaOH溶液,加至PH为12左右,抽虑得红色固体为1-(4-氯苯基)-1-(2-吡啶基)甲酮和杂质。加入60ml正己烷和3g活性碳加热回流1小时。过滤活性碳得正己烷溶液。最后将正己烷溶液冷却结晶得白色固体为1-(4-氯苯基)-1-(2-吡啶基)甲酮,过滤,水洗,抽干后,于真空干燥箱中50℃干燥得白色粉末固体1-(4-氯苯基)-1-(2-吡啶基)甲酮1.17g。回收正己烷后的残留物经柱层析(硅胶200~300目,洗脱剂:V乙酸乙酯∶V石油醚=1∶3)分离得到产物0.17g,总共得产物1-(4-氯苯基)-1-(2-吡啶基)甲酮1.27g,收率为31.2%。熔点:60-61℃;GC-MS:98%。 Add 2.46g of 2-pyridinecarboxylic acid into a 100ml reaction flask, then slowly add 10ml of thionyl chloride into the constant pressure dropping funnel, slowly raise the temperature to reflux, and react for 3 hours. Heating was stopped, and the remaining thionyl chloride was recovered under reduced pressure to obtain a dark red solid of 2-pyridinecarbonyl chloride hydrochloride. Add 20ml of chlorobenzene under the condition of ice bath, slowly add 7.24g of aluminum trichloride under stirring, continue to stir after the addition, after half an hour, transfer the reaction bottle to an oil bath and slowly heat to about 108°C, and react for 6 hours , stop responding. Recover the remaining chlorobenzene under reduced pressure, and then slowly add ice cubes (made by adding 2ml of concentrated hydrochloric acid to 20ml of water) under ice bath conditions. The reaction is very violent, and ice cubes should be added carefully. Then slowly add concentrated NaOH solution until the pH is about 12, and the red solid is 1-(4-chlorophenyl)-1-(2-pyridyl)methanone and impurities by filtration. Add 60ml of n-hexane and 3g of activated carbon and heat to reflux for 1 hour. Filter activated carbon to obtain n-hexane solution. Finally, the n-hexane solution was cooled and crystallized to obtain a white solid 1-(4-chlorophenyl)-1-(2-pyridyl)methanone, which was filtered, washed with water, and dried in a vacuum oven at 50°C to obtain a white solid. 1.17 g of powder solid 1-(4-chlorophenyl)-1-(2-pyridyl)methanone. The residue after recovering n-hexane was separated by column chromatography (silica gel 200-300 mesh, eluent: V ethyl acetate : V petroleum ether = 1:3) to obtain 0.17 g of the product, and the product 1-(4-chloro 1.27 g of phenyl)-1-(2-pyridyl)methanone, the yield was 31.2%. Melting point: 60-61°C; GC-MS: 98%.
取上述所制得1-(4-氯苯基)-1-(2-吡啶基)甲酮2.18g,加入一缩二乙二醇6ml,85%水合肼12ml,氢氧化钾1.3g,回流1小时,然后一边升高反应温度一边将反应瓶内的水蒸出。将温度升至200℃,反应8小时。冷却后加入100ml水,用10ml×3甲苯萃取,回收甲苯后减压蒸馏得无色油状液体2-对氯苄基吡啶1.73g,收率85%;GC-MS:99%。 Take 2.18g of 1-(4-chlorophenyl)-1-(2-pyridyl)methanone obtained above, add 6ml of diethylene glycol, 12ml of 85% hydrazine hydrate, 1.3g of potassium hydroxide, and reflux After 1 hour, the water in the reaction bottle was distilled off while raising the reaction temperature. The temperature was raised to 200°C and reacted for 8 hours. After cooling, add 100ml of water, extract with 10ml×3 toluene, recover the toluene and distill under reduced pressure to obtain 1.73g of 2-p-chlorobenzylpyridine as a colorless oily liquid, with a yield of 85%; GC-MS: 99%. the
实施例3 制备2-对氯苄基吡啶 Example 3 Preparation of 2-p-chlorobenzylpyridine
加入2.46g 2-吡啶甲酸于100ml反应瓶中,然后将10ml氯化亚砜于恒压滴液漏斗慢慢加入其中,慢慢升温至回流,反应3小时。停止加热,减压回收剩余的氯化亚砜,得深红色固体为2-吡啶甲酰氯盐酸盐。冰浴条件下加入20ml氯苯,搅拌下慢慢加入6.7g三氯化铝,加毕,继续搅拌,半小时后将反应瓶转入油浴锅中慢慢加热至145℃左右,反应10小时,停止反应。减压回收剩余氯苯,然后在冰浴条件下慢慢加入冰块(20ml水中加有2ml浓盐酸冻制成),反应十分剧烈,应小心加入冰块。再慢慢加入浓NaOH溶液,加至PH为12左右,抽虑得红色固体为1-(4-氯苯基)-1-(2-吡啶基)甲酮和杂质。加入60ml正 己烷和3g活性碳加热回流1小时。过滤活性碳得正己烷溶液。最后将正己烷溶液冷却结晶得白色固体为1-(4-氯苯基)-1-(2-吡啶基)甲酮,过滤,水洗,抽干后,于真空干燥箱中50℃干燥得白色粉末固体1-(4-氯苯基)-1-(2-吡啶基)甲酮0.31g。回收正己烷后的残留物经柱层析(硅胶200~300目,洗脱剂:V乙酸乙酯∶V石油醚=1∶3)分离得到产物0.09g,总共得产物1-(4-氯苯基)-1-(2-吡啶基)甲酮0.4g,收率为10.1%;熔点:60-61℃;GC-MS:98%。 Add 2.46g of 2-pyridinecarboxylic acid into a 100ml reaction flask, then slowly add 10ml of thionyl chloride into the constant pressure dropping funnel, slowly raise the temperature to reflux, and react for 3 hours. Heating was stopped, and the remaining thionyl chloride was recovered under reduced pressure to obtain a dark red solid of 2-pyridinecarbonyl chloride hydrochloride. Add 20ml of chlorobenzene under the condition of ice bath, slowly add 6.7g of aluminum trichloride under stirring, continue to stir after adding, transfer the reaction bottle into an oil bath pot and slowly heat to about 145°C after half an hour, and react for 10 hours , stop responding. Recover the remaining chlorobenzene under reduced pressure, and then slowly add ice cubes (made by adding 2ml of concentrated hydrochloric acid to 20ml of water) under ice bath conditions. The reaction is very violent, and ice cubes should be added carefully. Then slowly add concentrated NaOH solution until the pH is about 12, and the red solid is 1-(4-chlorophenyl)-1-(2-pyridyl)methanone and impurities by filtration. Add 60ml of n-hexane and 3g of active carbon and heat under reflux for 1 hour. Filter activated carbon to obtain n-hexane solution. Finally, the n-hexane solution was cooled and crystallized to obtain a white solid 1-(4-chlorophenyl)-1-(2-pyridyl)methanone, which was filtered, washed with water, and dried in a vacuum oven at 50°C to obtain a white solid. 0.31 g of powder solid 1-(4-chlorophenyl)-1-(2-pyridyl)methanone. The residue after recovering n-hexane was separated by column chromatography (silica gel 200-300 mesh, eluent: V ethyl acetate : V petroleum ether = 1:3) to obtain 0.09 g of the product, and a total of the product 1-(4-chloro Phenyl)-1-(2-pyridyl)methanone 0.4g, yield 10.1%; melting point: 60-61°C; GC-MS: 98%.
取上述所制得1-(4-氯苯基)-1-(2-吡啶基)甲酮2.18g,加入一缩二乙二醇6ml,85%水合肼12ml,氢氧化钾1.3g,回流1小时,然后一边升高反应温度一边将反应瓶内的水蒸出。将温度升至220℃,反应10小时。冷却后加入100ml水,用10ml×3甲苯萃取,回收甲苯后减压蒸馏得无色油状液体2-对氯苄基吡啶1.75g,收率86%;GC-MS:99%。 Take 2.18g of 1-(4-chlorophenyl)-1-(2-pyridyl)methanone obtained above, add 6ml of diethylene glycol, 12ml of 85% hydrazine hydrate, 1.3g of potassium hydroxide, and reflux After 1 hour, the water in the reaction bottle was distilled off while raising the reaction temperature. The temperature was raised to 220° C. and reacted for 10 hours. After cooling, add 100ml of water, extract with 10ml×3 toluene, recover toluene and distill under reduced pressure to obtain 1.75g of colorless oily liquid 2-p-chlorobenzylpyridine, yield 86%; GC-MS: 99%. the
实施例4:制备扑尔敏 Embodiment 4: prepare chlorpheniramine
1.取用实施例1-3所述任一方法制备的2-对氯苄基吡啶; 1. Take the 2-p-chlorobenzylpyridine prepared by any method described in Examples 1-3;
2.制备扑尔敏盐基1-(4-氯苯基)-1-(2-吡啶基)-3-二甲胺基丙烷: 2. Preparation of chlorpheniramine base 1-(4-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane:
称取氨基钠0.6g于甲苯溶液中碾碎,将其加入含4ml甲苯的三口烧瓶中,再加入0.06g的十六烷基三甲基溴化铵,加热回流,然后慢慢滴加2-对氯苄基吡啶2g和2.13g溶于5ml甲苯的溶液。回流反应6小时,冷却后过滤得含扑尔敏盐基的甲苯溶液。回收甲苯后减压蒸馏得暗红色油状液体扑尔敏盐基1.8g。收率67%。 Weigh 0.6g of sodium amide and crush it in toluene solution, add it into a three-necked flask containing 4ml of toluene, then add 0.06g of cetyltrimethylammonium bromide, heat to reflux, and then slowly add 2- A solution of 2g and 2.13g of p-chlorobenzylpyridine dissolved in 5ml of toluene. Reflux reaction for 6 hours, filter after cooling to obtain a toluene solution containing chlorpheniramine base. After recovering toluene, distilled under reduced pressure to obtain 1.8 g of dark red oily liquid chlorpheniramine base. Yield 67%. the
3.制备扑尔敏1-(4-氯苯基)-1-(2-吡啶基)-3-二甲胺基丙烷顺丁烯二酸盐:将扑尔敏盐基与顺丁烯二酸成盐得扑尔敏成品。 3. Preparation of chlorpheniramine 1-(4-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane maleate: combine chlorpheniramine base with maleic di Acid into salt to get chlorpheniramine finished product. the
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010100456228A CN101967120A (en) | 2010-01-08 | 2010-01-08 | Preparation method of 2-p-chlorobenzyl pyridine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010100456228A CN101967120A (en) | 2010-01-08 | 2010-01-08 | Preparation method of 2-p-chlorobenzyl pyridine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101967120A true CN101967120A (en) | 2011-02-09 |
Family
ID=43546356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010100456228A Pending CN101967120A (en) | 2010-01-08 | 2010-01-08 | Preparation method of 2-p-chlorobenzyl pyridine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101967120A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103787958A (en) * | 2014-03-10 | 2014-05-14 | 悦康药业集团有限公司 | Chlorpheniramine maleate compound and pharmaceutical composition thereof |
CN105175318A (en) * | 2015-07-29 | 2015-12-23 | 张燕梅 | Synthesis method of pheniramine maleate |
CN105237469A (en) * | 2015-10-27 | 2016-01-13 | 杭州澳医保灵药业有限公司 | Preparation method of 4-chlorophenyl-2-pyridyl methanol |
CN106883167A (en) * | 2015-12-16 | 2017-06-23 | 张燕梅 | A kind of new chlorphenamine maleate synthetic method |
CN110372578A (en) * | 2019-05-31 | 2019-10-25 | 嘉实(湖南)医药科技有限公司 | A kind of new chlorphenamine maleate synthetic method |
-
2010
- 2010-01-08 CN CN2010100456228A patent/CN101967120A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103787958A (en) * | 2014-03-10 | 2014-05-14 | 悦康药业集团有限公司 | Chlorpheniramine maleate compound and pharmaceutical composition thereof |
CN103787958B (en) * | 2014-03-10 | 2016-01-27 | 悦康药业集团有限公司 | Chlorpheniramine maleate compound and pharmaceutical composition thereof |
CN105175318A (en) * | 2015-07-29 | 2015-12-23 | 张燕梅 | Synthesis method of pheniramine maleate |
CN105237469A (en) * | 2015-10-27 | 2016-01-13 | 杭州澳医保灵药业有限公司 | Preparation method of 4-chlorophenyl-2-pyridyl methanol |
CN106883167A (en) * | 2015-12-16 | 2017-06-23 | 张燕梅 | A kind of new chlorphenamine maleate synthetic method |
CN110372578A (en) * | 2019-05-31 | 2019-10-25 | 嘉实(湖南)医药科技有限公司 | A kind of new chlorphenamine maleate synthetic method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102351720B (en) | A kind of simple and efficient synthetic method of ammonium bromide | |
CN101967120A (en) | Preparation method of 2-p-chlorobenzyl pyridine | |
CN102108070B (en) | Preparation methods of 5-aminobenzofuran-2-formate and intermediate thereof | |
CN103224473B (en) | Preparation method of triazine ring | |
CN105330540B (en) | Montelukast receives the preparation method of intermediate | |
CN101891646A (en) | Preparation method of pentachlorohydrazide | |
CN105541714A (en) | Preparation methods of papaverine and papaverine hydrochloride | |
CN105153083B (en) | Preparation method for polysubstituted furan compound | |
CN100537552C (en) | A kind of method for preparing repaglinide | |
CN102060717A (en) | The synthetic method of 3-amino-4-bromophenol | |
CN104876883B (en) | The synthetic method of anti-insomnia medicine Su Woleisheng intermediates | |
CN102603571B (en) | Preparation method of 2,4-dichloro-3-cyano-5-fluobenzoic acid | |
CN107056685A (en) | A kind of synthetic method of doxylamine succinate | |
CN104496995A (en) | Method for preparing 3-ethynyl imidazo[1,2-b]pyridazine | |
CN116496223A (en) | A kind of preparation method of 5-bromo-4-methyl-2-trifluoromethylpyrimidine | |
CN106243022A (en) | A kind of preparation method of nevirapine intermediate | |
CN103275003A (en) | Method for preparing phenanthridinone derivative | |
CN107698501A (en) | The preparation technology of the hydroxy niacin of 5,6 dimethyl 2 | |
CN107417604A (en) | Benzamide compound of 4 substituted pyridines 2 and preparation method and application | |
CN102838597A (en) | Preparation method of heteroaromatic iminazole [1,2-Alpha]pyridine compounds | |
CN106243009A (en) | A kind of preparation method of 3 n-butylamine-based 4 bromine N phenyl maleimides | |
CN102000605A (en) | Catalytic initiator Cu2(L)Cl2 of monovalent copper and its preparation method, preparation method of nitrogen heterocyclic aromatization product | |
CN105085496A (en) | Method for preparing Lapatinib and intermediate | |
CN102633646B (en) | New preparation method of 5-nitro-salicylaldehyde | |
CN105777625B (en) | A kind of method for preparing 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20110209 |